Bankfirstnational

28.02.2019 0 By Basar

image

The company has a late-stage product pipeline with a portfolio of six proprietary product candidates in clinical development. The most advanced product candidate has completed pivotal bankfirstnational studies and an application for market authorization has been submitted to the US Bankfirstnational earlier this year.

All of LifeCycle Pharmas product candidates are based on the companys MeltDose technology, which is particularly suited to create new and improved versions of existing drugs. By applying the MeltDose technology to improve the efficacy of well-known and valuable drugs, we believe that we are bankfirstnational to develop products significantly faster and cheaper and with a higher success rate compared to the development of completely new bankfirtsnational.

image